High-dose melphalan chemotherapy with autologous stem cell transplant in 63 patients with AL amyloidosis:: Experiences in a centre

被引：0
|
作者：
Schoenland, S.
Hegenbart, U.
Dengler, J.
Bochtler, T.
Hundemer, M.
Singer, R.
Hund, E.
Beimler, J.
Zeier, M.
Kristen, A.
Dengler, T.
Ho, A.
Goldschmidt, H.
机构：
[1] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany
[2] Univ Klinikum Heidelberg, Chirurg Klin, Heidelberg, Germany
[3] Univ Klinikum Heidelberg, Neurol Klin, Heidelberg, Germany
[4] Univ Klinikum Heidelberg, Nierenzentrum, Heidelberg, Germany
[5] Univ Klinikum Heidelberg, Med Klin 3, Heidelberg, Germany
来源：
MEDIZINISCHE KLINIK | 2006年 / 101卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：864 / 865
页数：2
相关论文
共 50 条
  • [21] Melphalan and high-dose dexamethasone in patients with AL (primary) amyloidosis ineligible for autologous stem cell transplantation.
    Palladini, G
    Perfetti, V
    Obici, L
    Merlini, G
    BLOOD, 2002, 100 (11) : 397A - 398A
  • [22] High-dose chemotherapy with autologous stem cell transplantation in systemic AL amyloidosis: A single centre experience of 20 patients.
    Amoura, Z
    Costedoat, N
    Azar, N
    Montalescot, G
    De Zuttere, D
    Mercadal, L
    Cacoub, P
    Leblond, V
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S122 - S122
  • [23] Outcome of High Dose Melphalan with Autologous Hematopoietic Stem Cell Transplant In Myeloma Associated with AL Amyloidosis
    Parmar, Simrit
    Khan, Mubeen
    Rondon, Gabriela
    Shah, Nina
    Bashir, Qaiser
    Tung, Shawndeep
    Shah, Jatin J.
    Weber, Donna
    Orlowski, Robert Z.
    Giralt, Sergio
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD, 2010, 116 (21) : 995 - 995
  • [24] High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement
    Girnius, Saulius
    Seldin, David C.
    Quillen, Karen
    Andrea, Nancy T.
    Sloan, John Mark
    Berk, John L.
    Ruberg, Frederick L.
    Meier-Ewert, Hans
    Sanchorawala, Vaishali
    BLOOD, 2011, 118 (21) : 896 - 896
  • [25] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    J B Perz
    A Rahemtulla
    C Giles
    R M Szydlo
    J Davis
    D Gopaul
    J Gillmore
    C J Mathias
    P N Hawkins
    J F Apperley
    Bone Marrow Transplantation, 2006, 37 : 937 - 943
  • [26] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    Perz, JB
    Rahemtulla, A
    Giles, C
    Szydlo, RM
    Davis, J
    Gopaul, D
    Gillmore, J
    Mathias, CJ
    Hawkins, PN
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 937 - 943
  • [27] High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study
    Skinner, M
    Sanchorawala, V
    Seldin, DC
    Dember, LM
    Falk, RH
    Berk, JL
    Anderson, JJ
    O'Hara, C
    Finn, KT
    Libbey, CA
    Wiesman, J
    Quillen, K
    Swan, N
    Wright, DG
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (02) : 85 - 93
  • [28] Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65
    Seldin, David C.
    Anderson, Jennifer J.
    Skinner, Martha
    Malek, Karim
    Wright, Daniel G.
    Quillen, Karen
    Finn, Kathleen
    Oran, Betul
    Sanchorawala, Vaishali
    BLOOD, 2006, 108 (12) : 3945 - 3947
  • [29] Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner's perspective
    Bomsztyk, Joshua
    Khwaja, Jahanzaib
    Wechalekar, Ashutosh D.
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (09) : 781 - 788
  • [30] High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma
    Lahoud, Oscar B.
    Sauter, Craig S.
    Hamlin, Paul A.
    Dahi, Parastoo Bahrami
    CURRENT ONCOLOGY REPORTS, 2015, 17 (09)
12345